Disbrow Joshua R. 4
4 · AYTU BIOPHARMA, INC · Filed Nov 8, 2024
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-11-06+38,000→ 38,000 totalExercise: $1.84Exp: 2034-11-06→ Common Shares (38,000 underlying)
Footnotes (1)
- [F1]The options vest as follows: 1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025.